{"transactions":[{"id":748293,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:11:22.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increased the number of shares of common stock authorized for issuance under the Plan (the \"Plan Amendment\"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026."}],"balance_after":42688,"source":{"system":"sec-edgar","filing":"0001193125-26-259927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000119312526259927/ownership.xml","form_type":"4"}},{"id":824331,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:15:06.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\"). The RSUs vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increases the number of shares of common stock authorized for issuance under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,000 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2025."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001193125-26-134601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000119312526134601/ownership.xml","form_type":"4"}},{"id":1186679,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-01T20:05:03.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":24200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029."}],"balance_after":24200,"derivative":{"exercise_price":10.62,"expiration_date":"2035-03-29","underlying":"Common Stock","underlying_shares":24200},"source":{"system":"sec-edgar","filing":"0000950170-25-048483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000095017025048483/ownership.xml","form_type":"4"}},{"id":1744309,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-11-13T21:10:21.000Z","date":"2023-11-08","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, November 8, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on November 8, 2027."}],"balance_after":500000,"derivative":{"exercise_price":0.85,"expiration_date":"2033-11-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-054973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000120919123054973/doc4.xml","form_type":"4"}}]}